This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sinovac Biotech Ltd (SVA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 107.24M 91.24M 104.29M 101.59M
Receivables 31.93M 23.44M 17.83M 25.77M
Inventories 14.33M 10.53M 8.11M 14.86M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 157.25M 126.28M 132.04M 147.29M
Property, Plant & Equipment, Gross 95.42M 101.13M 91.65M 74.88M
Accumulated Depreciation & Depletion 27.46M 21.05M 16.02M 10.84M
Property, Plant & Equipment, Net 67.96M 80.08M 75.63M 64.04M
Intangibles 772.00K 1.15M 1.34M 1.35M
Other Non-Current Assets 14.59M 801.74K 6.49M 1.17M
Total Non-Current Assets 83.44M 82.48M 83.87M 67.06M
Liabilities & Shareholder Equity
Total Assets 240.69M 208.76M 215.91M 214.36M
Accounts Payable 17.07M 15.24M 22.75M 13.54M
Short Term Debt 19.54M 3.33M 4.71M 10.44M
Other Current Liabilities 3.00M 2.69M 6.80M 2.54M
Total Current Liabilities 49.16M 30.15M 40.64M 45.76M
Long Term Debt 32.15M 31.18M 17.32M 10.06M
Deferred Income Taxes 0.00 4.07M 0.00 0.00
Other Non-Current Liabilities 15.75M 13.92M 12.65M 10.79M
Minority Interest 2.93M -3.90M 445.00K -4.09M
Total Non-Current Liabilities 62.85M 60.88M 45.34M 42.16M
Total Liabilities 112.01M 91.04M 85.99M 87.92M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 128.68M 117.72M 129.92M 126.44M
Common Par 56.00K 55.09K 54.77K 54.31K
Additional Paid In Capital 107.39M 106.25M 117.19M 104.15M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -4.71M -12.16M 2.70M 3.88M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 25.95M 23.58M 9.98M 18.36M
Total Capitalization 160.83M 148.91M 147.24M 136.50M
Total Equity 128.68M 117.72M 129.92M 126.44M
Total Liabilities & Stock Equity 240.69M 208.76M 215.91M 214.36M
Total Common Shares Outstanding 55.57M 55.09M 54.77M 54.31M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 55.30M 54.93M 54.61M 53.06M
Diluted Weighted Shares Outstanding 55.80M 54.93M 54.61M 53.06M
Number of Employees 715 652 614 483
Number of Part-Time Employees 0 0 0 0
SVA News

SVA Sinovac Biotech Ltd

Analysts Ratings for SVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SVA ANALYST REPORT

Brokerage Partners

SVA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs